On 28 October 2022, the 1/4/6x24 Campaign Coalition hosted a session at the USAID TB Symposium '1/4/6x24 Campaign Call to Action: Kick Starting Momentum Toward the United Nations High-Level Meeting.' Full details about the event are available here.
The event featured speakers from several high-burden countries, including TB survivors and national TB program representatives, and civil society organizations who outlined the 1/4/6x24 Campaign. The event featured as well exclusive announcements of key commitments for the Campaign. Detailed information about the Campaign, including the commitments made so far, can be accessed here.
The 1/4/6x24 Campaign’s central demand seeks to catalyze into meaningful action recent scientific progress enabling safer, shorter cures recommended by the World Health Organization for nearly all forms of TB: one month or once-weekly regimens for TB prevention, four-month regimens for drug-sensitive TB, and six-month regimens for drug-resistant TB – by the end of 2024.